DXCM DexCom, Inc.

DXCM DexCom, Inc.

Healthcare · Medical Devices

Desk view

Watchingmedium conviction · entry <$65 — not entered
Basis Entry target
Updated

Market read

Scan convergence 2 scans as of 2026-08-14 2 bull converging

POC $67.50 · VWAP $69.04 · +28.6% vs 12m avg buyer

breakout vol: normalgaps: stablechurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

DXCM Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist DXCM belongs to, members best 30-day change first — DXCM highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@healthcare-scan
@healthcare
@biotech-scan

Next earnings DXCM reports in 72 days Oct 29

Against street estimates

How DXCM's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 30 · projection Aug 17

Result
Jul 30 0.610.70+15.1%Beat
Apr 30 0.470.56+19.0%Beat
Feb 12 0.650.68+4.5%Beat
Oct 30 '25 0.570.61+7.5%Beat
Jul 30 '25 0.440.48+8.3%Beat
May 1 '25 0.330.32-2.6%Miss
Feb 13 '25 0.500.45-9.9%Miss
Oct 24 '24 0.430.45 GAAP ≠ +3.5%Beat

News (last pull)

Headlines about DXCM from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 58 days ago · Jun 21

Types
Jul 30 Catalyst DXCM earnings
Jul 29 Catalyst DXCM earnings